XML 139 R113.htm IDEA: XBRL DOCUMENT v3.21.2
Loss per Share, Antidilutive (FY) (Details) - shares
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Antidilutive Securities [Abstract]              
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares) 33,491,000 28,873,000 33,491,000 28,873,000 16,275,742 11,758,416 12,696,775
Options to Purchase Common Stock [Member]              
Antidilutive Securities [Abstract]              
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares) 20,347,000 16,373,000 20,347,000 16,373,000 16,170,737 11,653,411 12,591,770
Series C Warrants [Member]              
Antidilutive Securities [Abstract]              
Anti-dilutive securities excluded from computation of diluted earnings per share (in shares) 12,498,000 12,500,000 12,498,000 12,500,000 105,005 105,005 105,005